Does BioAge identify accelerated aging in individuals with bipolar disorder? An exploratory study in the FACE-BD cohort
- PMID: 39085169
- DOI: 10.1111/bdi.13480
Does BioAge identify accelerated aging in individuals with bipolar disorder? An exploratory study in the FACE-BD cohort
Abstract
Background: Individuals with bipolar disorders (BD) have an estimated loss of life expectancy around 10-15 years. Several laboratory-measured biomarkers of accelerated aging exist (e.g., telomere length), however with a questionable transferability to bedside. There is a need for easily and inexpensively measurable markers of aging, usable in routine practice, such as BioAge.
Methods: We calculated BioAge that estimates biological age based on routine blood tests and a physical exam, in a sample of 2220 outpatients with BD. We investigated associations between BioAge Acceleration (BioAgeAccel), which is an indicator of accelerated aging, and sociodemographic variables, clinical variables, and current psychotropic medication use.
Results: Mean chronological age was 40.2 (±12.9). Mean BioAge was 39.1 (±12.4). Mean BioAgeAccel was 0.08 (±1.8). A minority of individuals (15%) had a BioAgeAccel above 2 years. Multivariable analyses suggested strong associations between a higher BioAgeAccel and younger age, male sex, overweight and sleep disturbances. Regarding current psychotropic medication use, discrepancies between univariate and multivariate analyses were observed.
Conclusions: A minority of individuals with BD had an accelerated aging as measured by BioAge. We identified associations with potentially modifiable factors, such as higher body mass index and sleep disturbances, that are however nonspecific to BD. These results require replications in independent samples of individuals with BD, and comparisons with a control group matched for age and gender. Longitudinal studies are also required to test whether any change in metabolic health, or sleep might decrease BioAgeAccel.
Keywords: accelerated aging; bioage; biological age; bipolar disorder; determinants; medications; obesity; sleep.
© 2024 The Author(s). Bipolar Disorders published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Chan JKN, Tong CHY, Wong CSM, et al. Life expectancy and years of potential life lost in bipolar disorder: systematic review and meta‐analysis. Br J Psychiatry. 2022;221(3):567‐576.
-
- Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163‐180.
-
- Hayes JF, Miles J, Walters K, King M, Osborn DPJ. A systematic review and meta‐analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand. 2015;131(6):417‐425.
-
- Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta‐analysis. JAMA Psychiatry. 2015;72(4):334‐341.
-
- Chang CK, Hayes RD, Perera G, et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One. 2011;6(5):e19590.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical